期刊文献+

妊娠期肝内胆汁淤积症合并HDP患者凝血功能、血流动力学变化及母婴结局分析 被引量:1

Analysis of the changes of coagulation function and hemodynamics,and the maternal-neonatal outcomes of women with intrahepatic cholestasis of pregnancy complicated with hypertensive disorder complicating pregnancy
下载PDF
导出
摘要 目的:探讨妊娠期肝内胆汁淤积症(ICP)合并妊娠期高血压疾病(HDP)患者凝血功能、血流动力学变化及其母婴结局。方法:回顾性收集2019年6月-2023年6月本院收治的ICP产妇(ICP组)、ICP合并HDP产妇(ICP合并HDP组)、健康产妇(对照组)各60例临床资料,分析各组凝血指标与血流动力学指标变化,统计其母婴结局。结果:对照组、ICP组、ICP合并HDP组血清凝血酶原时间(12.19±1.39s、11.18±1.05s、10.62±1.22s),凝血酶时间(16.15±0.72s、15.24±0.66s、13.12±0.62s)、活化部分凝血酶时间(35.37±4.18s、32.05±3.27s、30.40±3.04s)依次降低,纤维蛋白原(4.15±0.45g/L、4.58±0.52g/L、4.98±0.61g/L)、脐动脉阻力指数、搏动指数及收缩期峰值流速与舒张末期血流速度比值依次升高,分娩孕周(39.3±1.6周、38.4±1.7周、38.0±1.4周)依次降低,剖宫产及羊水污染II度以上发生率依次升高,早产(1.7%、15.0%、18.3%)、低体重儿(0、6.7%、10.0%)、新生儿窒息(0、10.0%、13.3%)发生率依次升高(均P<0.05),但3组胎死宫内发生率未见差异(P>0.05)。结论:ICP合并HDP患者凝血功能与血流动力学变化显著,可影响母婴结局,密切监测相关指标对临床改善母婴结局等具有重要意义。 Objective:To investigate the changes of coagulation function and hemodynamics,and the maternal-neonatal outcomes of pregnant women with intrahepatic cholestasis of pregnancy(ICP)complicated with hypertensive disorder complicating pregnancy(HDP).Methods:The clinical data of 60 pregnant women with ICP in group A,60 pregnant women with ICP complicated with HDP in group B and 60 healthy pregnant women in group C from June 2019 to June 2023 were collected retrospectively.The changes of coagulation function and hemodynamics of the women in the three groups were analyzed.The maternal-neonatal outcomes of the women in the three groups were counted.Results:The serum prothrombin time(12.19±1.39s,11.18±1.05s and 10.62±1.22s),the thrombin time(16.15±0.72s,15.24±0.66s and 13.12±0.62s),and the activated partial thromboplastin time(26.37±4.18s,25.06±3.27s and 23.41±3.05 s)of the women in group C,in group A and in group B had decreased gradually.The fibrinogen level(4.15±0.45 g/L,4.58±0.52 g/L,4.98±0.61 g/L),the values of umbilical artery resistance index,pulsatility index and the ratio of the peak systolic velocity to the end diastolic velocity of the women in group C,in group A and in group B had increased gradually.The delivery gestational weeks(39.3±1.6 weeks,38.4±1.7 weeks and 38.0±1.4 weeks)of the women in group C,in group A and in group B had decreased gradually.The incidences of cesarean section and amniotic fluid con-tamination above gradeⅡof the women in group C,in group A and in group B had increased gradually.The incidences of the preterm birth(1.7%,15.0%and 18.3%),the low birth weight(O,6.7%and 10.0%)and the neonatal asphyxia(0,10.0%and 13.3%)of the women in group C,in group A and in group B had increased gradually(all P<0.05).There was no significant difference in the incidence of intrauterine fetal death of the women among the three groups(P>0.05).Conclusion:The coagulation function and hemodynamic indicators of the pregnant women with ICP complicated with HDP have changed significantly,which can influence the maternal-neonatal outcomes.The close mo-nitoring the relevant indicators is of great significance for improving the maternal neonatal outcomes.
作者 吴克乐 肖文雅 WU Kele;XIAO Wenya(The Second Affiliated Hospital of Wenzhou Medical University,Wenzhou,Zhejiang Province,325000)
出处 《中国计划生育学杂志》 2024年第2期427-430,435,共5页 Chinese Journal of Family Planning
基金 温州市级科技计划项目(Y2023517)。
关键词 妊娠期肝内胆汁淤积症 妊娠期高血压 凝血功能 血流动力学 母婴结局 Intrahepatic cholestasis of pregnancy Hypertensive disorder complicating pregnancy Coagulation function Hemodynamic Maternal-neonatal outcomes
  • 相关文献

参考文献10

二级参考文献91

  • 1万云洁,蒋冰.胎儿生长受限与胎盘病理改变及胎儿脐血流关系的探讨[J].中国急救医学,2018,38(A01):185-185. 被引量:7
  • 2何洕,冯国芳.妊娠期肝内胆汁淤积症血液流变学和凝血时间变化及意义[J].中国妇幼保健,2005,20(8):991-993. 被引量:5
  • 3肖建平.126例妊娠期肝内胆汁淤积症胎儿脐血心肌酶检测的临床分析[J].中国妇产科临床杂志,2006,7(5):368-369. 被引量:5
  • 4American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy.Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy [J]. Obstet Gynecol, 2013, 122(5):1122-1131.
  • 5Magee LA, Pels A, Helewa M, et al.Canadian Hypertensive Disorders of Pregnancy Working Group. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary[J]. J Obstet Gynaecol Can, 2014, 36(5):416-441.
  • 6Visintin C, Mugglestone MA, Almerie MQ, et al. Management of hypertensive disorders during pregnancy: summary of NICE guidance[J]. BMJ, 2010, 341 :c2207.
  • 7Lowe SA, Bowyer L, Lust K, et al. The SOMANZ Guidelines for the Management of Hypertensive Disorders of Pregnancy 2014[J]. Aust N Z J Obstet Gynaecol, 2015, 55(1):11-16.
  • 8Campos-Outcah D Sr. US Preventive Services Task Force: the gold standard of evidence-based prevention[J]. J Fam Pract, 2005, 54(6):517-519.
  • 9Magee LA, Hdewa M, Momquin JM, et al. Diagnosis, evaluation,and management of the hypertensive disorders of pregnancy[J]. J Obstet Gynaeeol Can, 2008, 30 (Suppl): S1-48.
  • 10Cote AM, Brown MA, Laln E, et al. Diagnostic accuracy of urinary spot protein: creatiniue ratio for proteinuria in hypertensive pregnant women: systematic review[J]. BMJ, 2008, 336(7651): 1003-1006.

共引文献1614

同被引文献10

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部